BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo

BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo. Klein, E., Marsh, S., Becker, J., Andermann, M., Lehtinen, M., & Moore, C. I. Neurophotonics, 11(2):024210, SPIE, 2024.

Paper doi abstract bibtex

SignificanceThe choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the “LuMinOpsin” (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production.AimTo test the viability of BL-OG/LMO for ChP control.ApproachUsing transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices.ResultsMultiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast “flash” kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles.ConclusionsBL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.

@article{10.1117/1.NPh.11.2.024210,
	author = {Eric Klein and Sophie Marsh and Jordan Becker and Mark Andermann and Maria Lehtinen and Christopher  I. Moore},
	title = {{BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo}},
	volume = {11},
	journal = {Neurophotonics},
	number = {2},
	publisher = {SPIE},
	pages = {024210},
	abstract = {SignificanceThe choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the “LuMinOpsin” (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production.AimTo test the viability of BL-OG/LMO for ChP control.ApproachUsing transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices.ResultsMultiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast “flash” kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles.ConclusionsBL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.},
	keywords = {BioLuminescent, optogenetic, chemogenetic, dynamics, behavior, Optogenetics, In vivo imaging, Bioluminescence, Animals, Neurophotonics, Molecules, Modulation, Video, Signal processing, Skull},
	year = {2024},
	doi = {10.1117/1.NPh.11.2.024210},
	URL = {https://doi.org/10.1117/1.NPh.11.2.024210}
}

Downloads: 0

{"_id":"iYmx5dXpL5WhEbyPJ","bibbaseid":"klein-marsh-becker-andermann-lehtinen-moore-bioluminescentoptogeneticsinthechoroidplexusintegratedoptoandchemogeneticcontrolinvivo-2024","author_short":["Klein, E.","Marsh, S.","Becker, J.","Andermann, M.","Lehtinen, M.","Moore, C. I."],"bibdata":{"bibtype":"article","type":"article","author":[{"firstnames":["Eric"],"propositions":[],"lastnames":["Klein"],"suffixes":[]},{"firstnames":["Sophie"],"propositions":[],"lastnames":["Marsh"],"suffixes":[]},{"firstnames":["Jordan"],"propositions":[],"lastnames":["Becker"],"suffixes":[]},{"firstnames":["Mark"],"propositions":[],"lastnames":["Andermann"],"suffixes":[]},{"firstnames":["Maria"],"propositions":[],"lastnames":["Lehtinen"],"suffixes":[]},{"firstnames":["Christopher","I."],"propositions":[],"lastnames":["Moore"],"suffixes":[]}],"title":"BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo","volume":"11","journal":"Neurophotonics","number":"2","publisher":"SPIE","pages":"024210","abstract":"SignificanceThe choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the “LuMinOpsin” (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production.AimTo test the viability of BL-OG/LMO for ChP control.ApproachUsing transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices.ResultsMultiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast “flash” kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles.ConclusionsBL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.","keywords":"BioLuminescent, optogenetic, chemogenetic, dynamics, behavior, Optogenetics, In vivo imaging, Bioluminescence, Animals, Neurophotonics, Molecules, Modulation, Video, Signal processing, Skull","year":"2024","doi":"10.1117/1.NPh.11.2.024210","url":"https://doi.org/10.1117/1.NPh.11.2.024210","bibtex":"@article{10.1117/1.NPh.11.2.024210,\n\tauthor = {Eric Klein and Sophie Marsh and Jordan Becker and Mark Andermann and Maria Lehtinen and Christopher I. Moore},\n\ttitle = {{BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo}},\n\tvolume = {11},\n\tjournal = {Neurophotonics},\n\tnumber = {2},\n\tpublisher = {SPIE},\n\tpages = {024210},\n\tabstract = {SignificanceThe choroid plexus (ChP) epithelial network displays diverse dynamics, including propagating calcium waves and individuated fluctuations in single cells. These rapid events underscore the possibility that ChP dynamics may reflect behaviorally relevant and clinically important changes in information processing and signaling. Optogenetic and chemogenetic tools provide spatiotemporally precise and sustained approaches for testing such dynamics in vivo. Here, we describe the feasibility of a novel combined opto- and chemogenetic tool, BioLuminescent-OptoGenetics (BL-OG), for the ChP in vivo. In the “LuMinOpsin” (LMO) BL-OG strategy, a luciferase is tethered to an adjacent optogenetic element. This molecule allows chemogenetic activation when the opsin is driven by light produced through luciferase binding a small molecule (luciferin) or by conventional optogenetic light sources and BL-OG report of activation through light production.AimTo test the viability of BL-OG/LMO for ChP control.ApproachUsing transgenic and Cre-directed targeting to the ChP, we expressed LMO3 (a Gaussia luciferase-VChR1 fusion), a highly effective construct in neural systems. In mice expressing LMO3 in ChP, we directly imaged BL light production following multiple routes of coelenterazine (CTZ: luciferin) administration using an implanted cannula system. We also used home-cage videography with Deep LabCut analysis to test for any impact of repeated CTZ administration on basic health and behavioral indices.ResultsMultiple routes of CTZ administration drove BL photon production, including intracerebroventricular, intravenous, and intraperitoneal injection. Intravenous administration resulted in fast “flash” kinetics that diminished in seconds to minutes, and intraperitoneal administration resulted in slow rising activity that sustained hours. Mice showed no consistent impact of 1 week of intraperitoneal CTZ administration on weight, drinking, motor behavior, or sleep/wake cycles.ConclusionsBL-OG/LMO provides unique advantages for testing the role of ChP dynamics in biological processes.},\n\tkeywords = {BioLuminescent, optogenetic, chemogenetic, dynamics, behavior, Optogenetics, In vivo imaging, Bioluminescence, Animals, Neurophotonics, Molecules, Modulation, Video, Signal processing, Skull},\n\tyear = {2024},\n\tdoi = {10.1117/1.NPh.11.2.024210},\n\tURL = {https://doi.org/10.1117/1.NPh.11.2.024210}\n}\n\n\n","author_short":["Klein, E.","Marsh, S.","Becker, J.","Andermann, M.","Lehtinen, M.","Moore, C. I."],"key":"10.1117/1.NPh.11.2.024210","id":"10.1117/1.NPh.11.2.024210","bibbaseid":"klein-marsh-becker-andermann-lehtinen-moore-bioluminescentoptogeneticsinthechoroidplexusintegratedoptoandchemogeneticcontrolinvivo-2024","role":"author","urls":{"Paper":"https://doi.org/10.1117/1.NPh.11.2.024210"},"keyword":["BioLuminescent","optogenetic","chemogenetic","dynamics","behavior","Optogenetics","In vivo imaging","Bioluminescence","Animals","Neurophotonics","Molecules","Modulation","Video","Signal processing","Skull"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://neuronex1.github.io/pubs.bib","dataSources":["TvqYudBJxx7Hha9Hu"],"keywords":["bioluminescent","optogenetic","chemogenetic","dynamics","behavior","optogenetics","in vivo imaging","bioluminescence","animals","neurophotonics","molecules","modulation","video","signal processing","skull"],"search_terms":["bioluminescent","optogenetics","choroid","plexus","integrated","opto","chemogenetic","control","vivo","klein","marsh","becker","andermann","lehtinen","moore"],"title":"BioLuminescent OptoGenetics in the choroid plexus: integrated opto- and chemogenetic control in vivo","year":2024}